Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

17
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

11
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
11
Renal Corpuscle01:20

Renal Corpuscle

2.4K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.4K
Nephrons01:10

Nephrons

2.6K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.6K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

9
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
9

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Independent and Dose-Dependent Contributions of Clonal Hematopoiesis and Mosaic Loss of Y to Incident Heart Failure.

European journal of heart failure·2026
Same author

Disconnected universes: advanced kidney research versus absence of basic kidney care in high income countries.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Tubular MAG3 Extraction Rate is a Predictor of Short-Term and Long-Term Outcome After Kidney Transplantation: A Prospective Observational Study.

Clinical nuclear medicine·2025
Same author

The transaminase-ω-amidase pathway senses oxidative stress to control glutamine metabolism and α-ketoglutarate levels in endothelial cells.

The EMBO journal·2025
Same author

Loss of Y chromosome: proteomic signatures in human cardiovascular disease.

European heart journal·2025
Same author

Mosaic loss of Y chromosome and mortality after coronary angiography.

European heart journal·2025

Related Experiment Video

Updated: Jul 12, 2025

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
12:55

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation

Published on: December 9, 2021

3.3K

Leukocyte-endothelial interaction in CKD.

Tamim Sarakpi1,2, Armir Mesic1,2, Thimoteus Speer1,2

  • 1Department of Internal Medicine 4 - Nephrology, Goethe University Frankfurt, Frankfurt am Main, Germany.

Clinical Kidney Journal
|November 2, 2023
PubMed
Summary

Chronic kidney disease (CKD) significantly increases cardiovascular disease (CVD) risk and mortality. Targeting the NLRP3-IL-1β-IL-6 pathway offers a promising anti-inflammatory therapy for CKD patients with persistent inflammation.

Keywords:
adhesioncardiovascular diseasechronic kidney diseaseinflammation

More Related Videos

Assessing Leukocyte-endothelial Interactions Under Flow Conditions in an Ex Vivo Autoperfused Microflow Chamber Assay
09:01

Assessing Leukocyte-endothelial Interactions Under Flow Conditions in an Ex Vivo Autoperfused Microflow Chamber Assay

Published on: December 30, 2014

9.7K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.3K

Related Experiment Videos

Last Updated: Jul 12, 2025

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
12:55

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation

Published on: December 9, 2021

3.3K
Assessing Leukocyte-endothelial Interactions Under Flow Conditions in an Ex Vivo Autoperfused Microflow Chamber Assay
09:01

Assessing Leukocyte-endothelial Interactions Under Flow Conditions in an Ex Vivo Autoperfused Microflow Chamber Assay

Published on: December 30, 2014

9.7K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.3K

Area of Science:

  • Nephrology
  • Cardiology
  • Immunology

Background:

  • Chronic kidney disease (CKD) is a major independent risk factor for cardiovascular diseases (CVD), leading to increased cardiovascular mortality.
  • Inflammation, driven by endothelial cell and innate immune system interactions, is a key link between CKD and CVD.
  • CKD-induced uremic toxins cause vascular injury, endothelial dysfunction, and immune system activation, exacerbating CVD risk.

Purpose of the Study:

  • To explore the role of inflammation in the CKD-CVD link.
  • To investigate CKD-associated changes in monocytes and their impact on endothelial dysfunction.
  • To highlight the significance of the NLRP3-IL-1β-IL-6 pathway in CKD and CVD pathogenesis.

Main Methods:

  • Review of recent studies on CKD, CVD, inflammation, and immune system interactions.
  • Analysis of the role of uremic toxins in vascular injury and endothelial dysfunction.
  • Examination of the NLRP3-IL-1β-IL-6 signaling pathway in CKD and CVD.

Main Results:

  • CKD promotes vascular inflammation and endothelial dysfunction through metabolic changes and uremic toxins.
  • Monocyte alterations in CKD contribute to endothelial dysfunction, worsening CKD and associated CVD.
  • The NLRP3-IL-1β-IL-6 pathway is critically involved in the progression of both CKD and CVD.

Conclusions:

  • Targeted anti-inflammatory therapies, particularly inhibiting the NLRP3-IL-1β-IL-6 pathway, show potential for managing CKD-associated CVD.
  • CKD patients with nonresolving inflammation could significantly benefit from novel anti-inflammatory strategies.
  • Current therapeutic regimens have limited efficacy for CKD patients, underscoring the need for new approaches.